Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia

This publication has 14 references indexed in Scilit:

• Neuroprotective effects of a systemically active Group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia
  NeuroReport, 1998
• In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats
  Neuroscience Letters, 1997
• Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?
  Published by Elsevier ,1997
• A novel orally active Group 2 metabotropic glutamate receptor agonist
  NeuroReport, 1997
• Design, Synthesis, and Pharmacological Characterization of (+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY354740): A Potent, Selective, and Orally Active Group 2 Metabotropic Glutamate Receptor Agonist Possessing Anticonvulsant and Anxiolytic Properties
  Journal of Medicinal Chemistry, 1997
• Anticonvulsive and neuroprotective actions of a potent agonist (DCG-IV) for Group II metabotropic glutamate receptors against intraventricular kainate in the rat
  Neuroscience, 1997
• Activation of Class II or III Metabotropic Glutamate Receptors Protects Cultured Cortical Neurons Against Excitotoxic Degeneration
  European Journal of Neuroscience, 1995
• The inhibitory mGluR agonist, s-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death
  Neuropharmacology, 1995
• Activation of the metabotropic glutamate receptor is neuroprotective during nitric oxide toxicity in primary hippocampal neurons of rats
  Neuroscience Letters, 1995
• Activation of metabotropic receptors has a neuroprotective effect in a rodent model of focal ischaemia
  European Journal of Pharmacology, 1992